42 results
424B5
COCP
Cocrystal Pharma Inc
27 Aug 20
Prospectus supplement for primary offering
5:24pm
our intellectual property portfolio; and
attracting, hiring and retaining qualified personnel.
Because of the numerous risks and uncertainties
424B5
COCP
Cocrystal Pharma Inc
26 Aug 20
Prospectus supplement for primary offering
5:30pm
our intellectual property portfolio; and
attracting, hiring and retaining qualified personnel.
Because of the numerous risks and uncertainties
8-K
EX-1.1
4oyvxu
2 Jul 20
Entry into a Material Definitive Agreement
9:30am
424B5
aqs4t dzmvjuhthljb
1 Jul 20
Prospectus supplement for primary offering
4:49pm
8-K
EX-10.1
cql ze4tpp83u
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
424B5
6v2lr0l8r
10 Mar 20
Prospectus supplement for primary offering
3:04pm
8-K
EX-10.1
ksfazq5iv i4igi6
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
424B5
zmem u7wdfs7jm1l37uu
28 Feb 20
Prospectus supplement for primary offering
1:27pm
424B5
biuzsuebjyxer fnd
31 Jan 20
Prospectus supplement for primary offering
8:03am
8-K
EX-10.1
dpvt hxb8z9x21
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
424B5
rgvg6 x8v3y
31 Jan 20
Prospectus supplement for primary offering
8:01am
424B5
q1hh8oj
31 Oct 19
Prospectus supplement for primary offering
4:05pm
424B5
ee9ix2hy
31 Oct 19
Prospectus supplement for primary offering
4:02pm
424B5
q5pt0d hymf6up47mo
30 Oct 19
Prospectus supplement for primary offering
4:59pm
424B5
xsxivht56rj
20 Jul 18
Prospectus supplement for primary offering
4:46pm